共 109 条
- [1] Bray F(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries J Clin 68 394-424
- [2] Ferlay J(2020)Advances in molecular classification and precision oncology in hepatocellular carcinoma J Hepatol 72 215-229
- [3] Soerjomataram I(2018)The immunology of hepatocellular carcinoma Nat Immunol 19 222-232
- [4] Siegel RL(2017)Current progress in immunotherapy of hepatocellular carcinoma J Hepatol 66 482-484
- [5] Torre LA(2015)Much more than M1 and M2 macrophages, there are also CD169+ and TCR+ macrophages Front Immunol 6 263-596
- [6] Jemal A(2015)Macrophage-secreted IL-8 induces epithelial-mesenchymal transition in hepatocellular carcinoma cells by activating the JAK2/STAT3/Snail pathway Int J Oncol 46 587-36
- [7] Rebouissou S(2018)Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma Mol Cell Biochem 437 13-2502
- [8] Nault JC(2017)Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial Lancet 389 2492-17
- [9] Ringelhan M(2019)Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape Mol Camcer 18 1-169
- [10] Pfister D(2018)ImmPort, toward repurposing of open access immunological assay data for translational and clinical research Sci Dta 5 180015-890